311 related articles for article (PubMed ID: 33733052)
21. The Risk of Cutaneous Squamous Cell Carcinoma Among Patients with Type 2 Diabetes Receiving Hydrochlorothiazide: A Cohort Study.
de Haan-Du J; Landman GWD; Groenier KH; Vissers PAJ; Louwman MWJ; Kleefstra N; de Bock GH
Cancer Epidemiol Biomarkers Prev; 2021 Nov; 30(11):2114-2121. PubMed ID: 34493493
[TBL] [Abstract][Full Text] [Related]
22. Association between hydrochlorothiazide exposure and different incident skin, lip and oral cavity cancers: A series of population-based nested case-control studies.
Morales DR; Pacurariu A; Slattery J; Kurz X
Br J Clin Pharmacol; 2020 Jul; 86(7):1336-1345. PubMed ID: 32068906
[TBL] [Abstract][Full Text] [Related]
23. Hydrochlorothiazide use and the risk of skin cancer in patients with hypertensive disorder: a nationwide retrospective cohort study from Korea.
Park E; Lee Y; Jue MS
Korean J Intern Med; 2020 Jul; 35(4):917-928. PubMed ID: 31842528
[TBL] [Abstract][Full Text] [Related]
24. Use of antihypertensive drugs and risk of keratinocyte carcinoma: A meta-analysis of observational studies.
Tang H; Fu S; Zhai S; Song Y; Asgari MM; Han J
Pharmacoepidemiol Drug Saf; 2018 Mar; 27(3):279-288. PubMed ID: 29318704
[TBL] [Abstract][Full Text] [Related]
25. Association of Age, Sex, Race, and Geographic Region With Variation of the Ratio of Basal Cell to Cutaneous Squamous Cell Carcinomas in the United States.
Lukowiak TM; Aizman L; Perz A; Miller CJ; Sobanko JF; Shin TM; Giordano CN; Higgins HW; Etzkorn JR
JAMA Dermatol; 2020 Nov; 156(11):1192-1198. PubMed ID: 32845319
[TBL] [Abstract][Full Text] [Related]
26. Photosensitizing agents and the risk of non-melanoma skin cancer: a population-based case-control study.
Robinson SN; Zens MS; Perry AE; Spencer SK; Duell EJ; Karagas MR
J Invest Dermatol; 2013 Aug; 133(8):1950-5. PubMed ID: 23344461
[TBL] [Abstract][Full Text] [Related]
27. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis.
Marcil I; Stern RS
Arch Dermatol; 2000 Dec; 136(12):1524-30. PubMed ID: 11115165
[TBL] [Abstract][Full Text] [Related]
28. Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United States.
D'Arcy ME; Pfeiffer RM; Rivera DR; Hess GP; Cahoon EK; Arron ST; Brownell I; Cowen EW; Israni AK; Triplette MA; Yanik EL; Engels EA
JAMA Dermatol; 2020 Jul; 156(7):772-779. PubMed ID: 32401271
[TBL] [Abstract][Full Text] [Related]
29. Nonmelanoma skin and mucosal cancers after hematopoietic cell transplantation.
Leisenring W; Friedman DL; Flowers ME; Schwartz JL; Deeg HJ
J Clin Oncol; 2006 Mar; 24(7):1119-26. PubMed ID: 16461782
[TBL] [Abstract][Full Text] [Related]
30. Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer.
Karagas MR; Greenberg ER; Mott LA; Baron JA; Ernster VL
Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):157-61. PubMed ID: 9488591
[TBL] [Abstract][Full Text] [Related]
31. Incidence of and Risk Factors for Skin Cancer in Organ Transplant Recipients in the United States.
Garrett GL; Blanc PD; Boscardin J; Lloyd AA; Ahmed RL; Anthony T; Bibee K; Breithaupt A; Cannon J; Chen A; Cheng JY; Chiesa-Fuxench Z; Colegio OR; Curiel-Lewandrowski C; Del Guzzo CA; Disse M; Dowd M; Eilers R; Ortiz AE; Morris C; Golden SK; Graves MS; Griffin JR; Hopkins RS; Huang CC; Bae GH; Jambusaria A; Jennings TA; Jiang SI; Karia PS; Khetarpal S; Kim C; Klintmalm G; Konicke K; Koyfman SA; Lam C; Lee P; Leitenberger JJ; Loh T; Lowenstein S; Madankumar R; Moreau JF; Nijhawan RI; Ochoa S; Olasz EB; Otchere E; Otley C; Oulton J; Patel PH; Patel VA; Prabhu AV; Pugliano-Mauro M; Schmults CD; Schram S; Shih AF; Shin T; Soon S; Soriano T; Srivastava D; Stein JA; Sternhell-Blackwell K; Taylor S; Vidimos A; Wu P; Zajdel N; Zelac D; Arron ST
JAMA Dermatol; 2017 Mar; 153(3):296-303. PubMed ID: 28097368
[TBL] [Abstract][Full Text] [Related]
32. Chronic Use of Hydrochlorothiazide and Risk of Skin Cancer in Caucasian Adults: A PharmLines Initiative Inception Cohort Study.
Haisma MS; Greven N; Logendran M; Bos J; van der Vegt B; Horváth B; De Vos S; De Bock GH; Hak E; Rácz E
Acta Derm Venereol; 2023 Apr; 103():adv3933. PubMed ID: 37014269
[TBL] [Abstract][Full Text] [Related]
33. Risks of different skin tumour combinations after a first melanoma, squamous cell carcinoma and basal cell carcinoma in Dutch population-based cohorts: 1989-2009.
van der Leest RJT; Hollestein LM; Liu L; Nijsten T; de Vries E
J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):382-389. PubMed ID: 28898461
[TBL] [Abstract][Full Text] [Related]
34. Risks of Melanoma and Nonmelanoma Skin Cancers Pre- and Post-Inflammatory Bowel Disease Diagnosis.
Narous M; Nugent Z; Singh H; Bernstein CN
Inflamm Bowel Dis; 2023 Jul; 29(7):1047-1056. PubMed ID: 35929649
[TBL] [Abstract][Full Text] [Related]
35. Oral prednisone use and risk of keratinocyte carcinoma in non-transplant population. The VATTC trial.
Baibergenova AT; Weinstock MA;
J Eur Acad Dermatol Venereol; 2012 Sep; 26(9):1109-15. PubMed ID: 21923839
[TBL] [Abstract][Full Text] [Related]
36. History of Keratinocyte Carcinoma and Risk of Melanoma: A Prospective Cohort Study.
Wu S; Cho E; Li WQ; Qureshi AA
J Natl Cancer Inst; 2017 Apr; 109(4):. PubMed ID: 28376160
[TBL] [Abstract][Full Text] [Related]
37. Association of nonmelanoma skin cancer and actinic keratosis with cumulative solar ultraviolet exposure in Maryland watermen.
Vitasa BC; Taylor HR; Strickland PT; Rosenthal FS; West S; Abbey H; Ng SK; Munoz B; Emmett EA
Cancer; 1990 Jun; 65(12):2811-7. PubMed ID: 2340474
[TBL] [Abstract][Full Text] [Related]
38. Risk of skin cancer following tamoxifen treatment in more than 16,000 breast cancer patients: a cohort study.
Praestegaard C; Kjaer SK; Andersson M; Steding-Jensen M; Frederiksen K; Mellemkjaer L
Breast Cancer; 2016 Nov; 23(6):908-916. PubMed ID: 26660140
[TBL] [Abstract][Full Text] [Related]
39. Use of tanning beds and incidence of skin cancer.
Zhang M; Qureshi AA; Geller AC; Frazier L; Hunter DJ; Han J
J Clin Oncol; 2012 May; 30(14):1588-93. PubMed ID: 22370316
[TBL] [Abstract][Full Text] [Related]
40. Angiotensin II receptor antagonist telmisartan in isolated systolic hypertension (ARAMIS) study: efficacy and safety of telmisartan 20, 40 or 80 mg versus hydrochlorothiazide 12.5 mg or placebo.
Manolis AJ; Reid JL; de Zeeuw D; Murphy MB; Seewaldt-Becker E; Köster J;
J Hypertens; 2004 May; 22(5):1033-7. PubMed ID: 15097245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
